Preclinical assessment of the Absorption, Distribution, Metabolism and Excretion of HMPL-013, a novel potent and specific VEGFR inhibitor (ISSX 2011)

HMPL-013_Preclinical_17th_NA_ISSX_Oct20111-page-0